Arrhythmias are commonly encountered in the intensive care unit as a primary admitting diagnosis or secondary to an acute illness. Appropriate identification and treatment of ventricular arrhythmias in this setting are particularly important to reduce morbidity and mortality. This review highlights the epidemiology, mechanisms, electrocardiographic features, and treatment of ventricular arrhythmias.
ArtucioHPereiraM. Cardiac arrhythmias in critically ill patients: epidemiologic study. Crit Care Med. 1990;18(12):1383–1388.
2.
AnnaneDSebilleVDubocD, et al.Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med. 2008;178(3):20–25.
3.
ReineltPKarthGDGeppertAHeinzG. Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU. Intensive Care Med. 2001;27(2):1466–1473.
4.
ValderrabanoRJBlancoASantiago-RodriguezEJ, et al.Risk factors and clinical outcomes of arrhythmias in the medical intensive care unit. J Intensive Care. 2016;4(2):9.
5.
PageRLJoglarJACaldwellMA, et al.2015 ACC/AHA/HRS Guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American heart association task force on clinical practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67(3):e27–e115.
6.
BrugadaJKatritsisDGArbeloE, et al.2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The task force for the management of patients with supraventricular tachycardia of the European Society of Carrdiology (ESC): developed in collaboration with the Association for European Pediatric and Congenital Cardiology (AEPC). Eur Heart J. 2020;41(5):655–720.
7.
EnriquezAFrankelDSBaranchukA.Pathophysiology of ventricular tachyarrhythmias: from automaticity to reentry. Herzschrittmacherther Elektrophysiol. 2017;28(2):149–156.
8.
AntzelevitchCBurashnikovA. Overview of basic mechanisms of cardiac arrhythmia. Card Electrophysiol Clin. 2011;3(1):23–45.
9.
PrajapatiCPolonenRPAalto-SetalaK. Simultaneous recordings of action potentials and calcium transients from human induced pluripotent stem cell derived cardiomyocytes. Biol Open. 2018;7(7). pii: bio035030.
10.
DiFrancescoD. The pacemaker current (I(f)) plays an important role in regulating SA node pacemaker activity. Cardiovasc Res. 1995;30(2):307–308.
11.
KatzungBGMorgensternJA. Effects of extracellular potassium on ventricular automaticity and evidence for a pacemaker current in mammalian ventricular myocardium. Circ Res. 1977;40(8):105–111.
12.
CameronJSHanJ. Effects of epinephrine on automaticity and the incidence of arrhythmias in Purkinje fibers surviving myocardial infarction. J Pharmacol Exp Ther. 1982;223(7):573–579.
13.
NussHBKaabSKassDATomaselliGFMarbanE. Cellular basis of ventricular arrhythmias and abnormal automaticity in heart failure. Am J Physiol. 1999;277(5):H80–H91.
14.
MinesGR. On dynamic equilibrium in the heart. J Physiol. 1913;46(4):349–383.
15.
FrameLHPageRLHoffmanBF. Atrial reentry around an anatomic barrier with a partially refractory excitable gap. A canine model of atrial flutter. Circ Res. 1986;58(2):495–511.
16.
GoughWBMehraRRestivoMZeilerRHel-SherifN. Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog. 13. Correlation of activation and refractory maps. Circ Res. 1985;57(3):432–442.
17.
SchwartzPJWoosleyRL. Predicting the Unpredictable: drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol. 2016;67(2):1639–1650.
18.
JanuaryCTRiddleJM. Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current. Circ Res.1989;64(5):977–990.
19.
RodenDMAndersonME. The pause that refreshes, or does it? Mechanisms in torsades de pointes. Heart. 2000;84(1):235–237.
20.
BaltogiannisGGLysitsasDNdi GiovanniG, et al.CPVT: Arrhythmogenesis, therapeutic management, and future perspectives. A brief review of the literature. Front Cardiovasc Med. 2019;6(2):92.
21.
MarkowitzSMLitvakBLRamirez de ArellanoEAMarkiszJASteinKMLermanBB. Adenosine-sensitive ventricular tachycardia: right ventricular abnormalities delineated by magnetic resonance imaging. Circulation. 1997;96(1):1192–1200.
22.
NicholGSayreMRGuerraFPooleJ.Defibrillation for ventricular fibrillation: a shocking update. J Am Coll Cardiol. 2017;70(3):1496–1509.
23.
HochDHBatsfordWPGreenbergSM, et al.Double sequential external shocks for refractory ventricular fibrillation. J Am Coll Cardiol. 1994;23:1141–1145.
24.
CortezEKrebsWDavisJKesegDPPanchalAR. Use of double sequential external defibrillation for refractory ventricular fibrillation during out-of-hospital cardiac arrest. Resuscitation. 2016;108:82–86.
25.
RossEMRedmanTTHarperSAMappJGWamplerDAMiramontesDA. Dual defibrillation in out-of-hospital cardiac arrest: a retrospective cohort analysis. Resuscitation. 2016;106(2):14–17.
26.
JohnstonMCheskesSRossGVerbeekPR. Double sequential external defibrillation and survival from out-of-hospital cardiac arrest: a case report. Prehosp Emerg Care. 2016;20(2):662–666.
27.
PassmanRKadishA. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am. 2001;85(4):321–341.
28.
Al-KhatibSMStevensonWGAckermanMJ, et al.2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm. 2018;15:e73–e189.
29.
PrioriSGBlomstrom-LundqvistCMazzantiA, et al.2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015;17(3):1601–1687.
30.
LeiMWuLTerrarDAHuangCL. Modernized classification of cardiac antiarrhythmic drugs. Circulation. 2018;138(4):1879–1896.
31.
GomesJAKangPSHarimanRJEl-SherifNLyonsJ. Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone. Am Heart J. 1984;107(4):214–221.
32.
DesaiADChunSSungRJ. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann Intern Med. 1997;127(2):294–303.
33.
BurjorjeeJEMilneB. Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol. Can J Anaesth. 2002;49(2):973–977.
34.
ShivkumarK. Catheter ablation of ventricular arrhythmias. N Engl J Med. 2019;380(5):1555–1564.
35.
RihalCSNaiduSSGivertzMM, et al.2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol. 2015;65:e7–e26.
36.
De FerrariGMDusiVSpazzoliniC, et al.Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation. 2015;131(3):2185–2193.
37.
SchneiderHESteinmetzMKrauseUKriebelTRuschewskiWPaulT. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome. Clin Res Cardiol. 2013;102(6):33–42.
38.
SchwartzPJPrioriSGCerroneM, et al.Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109(2):1826–1833.
39.
WangLX. Role of left cardiac sympathetic denervation in the management of congenital long QT syndrome. J Postgrad Med. 2003;49(5):179–181.
40.
VaseghiMGimaJKanaanC, et al.Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm. 2014;11(2):360–366.
41.
Cardona-GuaracheRPadalaSKVelazco-DavilaL, et al.Stellate ganglion blockade and bilateral cardiac sympathetic denervation in patients with life-threatening ventricular arrhythmias. J Cardiovasc Electrophysiol.2017;28(2):903–908.
42.
FudimMBoortz-MarxRGaneshA, et al.Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017;28(3):1460–1467.
43.
MargusCCorreaACheungW, et al.Stellate ganglion nerve block by point-of-care ultrasonography for treatment of refractory infarction-induced ventricular fibrillation. Ann Emerg Med. 2020;75(2):257–260.
44.
SobotkaPAMayerJHBauernfeindRAKanakisCJrRosenKM. Arrhythmias documented by 24-hour continuous ambulatory electrocardiographic monitoring in young women without apparent heart disease. Am Heart J. 1981;101(1):753–759.
45.
BrodskyMWuDDenesPKanakisCRosenKM. Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol. 1977;39(2):390–395.
46.
HuizarJFEllenbogenKATanAYKaszalaK.Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(4):2328–2344.
47.
FlegJLLakattaEG. Prevalence and prognosis of exercise-induced nonsustained ventricular tachycardia in apparently healthy volunteers. Am J Cardiol. 1984;54(7):762–764.
48.
YangJCWesleyRCJrFroelicherVF. Ventricular tachycardia during routine treadmill testing. Risk and prognosis. Arch Intern Med. 1991;151(6):349–353.
49.
FlegJLKennedyHL. Long-term prognostic significance of ambulatory electrocardiographic findings in apparently healthy subjects greater than or equal to 60 years of age. Am J Cardiol. 1992;70(1):748–751.
ToninoWAPijlsNH. Accelerated idioventricular rhythm: a sign of reperfusion. Neth Heart J. 2005;13(1):464–465.
52.
KhanANadeemSKokaneH, et al.Is accelerated idioventricular rhythm a good marker for reperfusion after streptokinase?Indian Heart J. 2016;68(3):302–305.
53.
GorgelsAPVosMALetschIS, et al.Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol. 1988;61(2):231–235.
54.
De PontiRMarazzatoJMarazziR, et al.Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J. 2017;38(7):1329–1335.
55.
OrtizMMartinAArribasF, et al.Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J. 2017;38:1329–1335.
56.
SantangeliPMuserDMaedaS, et al.Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm.2016;13(3):1552–1559.
57.
www.crediblemeds.org. AZCERT; 2019.
58.
SchwartzPJPrioriSGSpazzoliniC, et al.Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103(1):89–95.
59.
KhanIA. Long QT syndrome: diagnosis and management. Am Heart J. 2002;143(2):7–14.
60.
TzivoniDKerenACohenAM, et al.Magnesium therapy for torsades de pointes. Am J Cardiol. 1984;53(2):528–530.
61.
KudenchukPJDayaMDorianP. Resuscitation outcomes consortium i. Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest. N Engl J Med.2016;375(1):802–803.
62.
DayaMRLerouxBGReaTD, et al.Survival after intravenous versus intraosseous amiodarone, lidocaine, or placebo in out-of-hospital ventricular fibrillation cardiac arrest. Circulation. 2018;138.
63.
Al-KhatibSMGrangerCBHuangY, et al.Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation. 2002;106(3):309–312.
64.
MehtaRHStarrAZLopesRD, et al.Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301(2):1779–1789.
65.
VolpiACavalliASantoroLNegriE. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction—results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-2) database. Am J Cardiol. 1998;82(2):265–271.
66.
LemkesJSJanssensGNvan der HoevenNW, et al.Coronary angiography after cardiac arrest without ST-segment elevation. N Engl J Med. 2019;380(2):1397–1407.
ObeyesekereMNKleinGJModiS, et al.How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol. 2011;4(3):958–964.
69.
IsraelCWBaroldSS. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol. 2007;12(6):375–382.
70.
ChatzidouSKontogiannisCTsilimigrasDI, et al.Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator. J Am Coll Cardiol. 2018;71(2):1897–1906.
71.
IsaacDChanMHaddadH, et al.Canadian Cardiac Transplant Network: Cardiac Transplantation: Eligibility and Listing Criteria in Canada; 2012. 2011.
ExnerDVPinskiSLWyseDG, et al.Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001;103(2):2066–2071.
74.
SesselbergHWMossAJMcNittS, et al.Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm. 2007;4(3):1395–1402.
75.
TkachenkoOShchekochikhinDSchrierRW. Hormones and hemodynamics is pregnancy. Int J Endocinol Metab. 2014;12(4):e14098.
76.
LiJMNguyenCJoglarJAHamdanMHPageRL. Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service. Clin Cardiol. 2008;31(2):538–541.
77.
PetersenEEDavisNLGoodmanD, et al.Vital signs: pregnancy-related deaths, united States, 2011-2015, and strategies for prevention, 13 States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019;68(4):423–429.
78.
KundraPKhannaSHabeebullahSRavishankarM. Manual displacement of the uterus during Caesarean section. Anaesthesia. 2007;62(6):460–465.
79.
JeejeebhoyFMZelopCMLipmanS, et al.Cardiac arrest in pregnancy: a scientific statement from the American heart association. Circulation. 2015;132(2):1747–1773.
80.
European Society of Gynecology (ESG), the Association for European Paediatric Cardiology (AEPC), and the German Society for Gender Medicine (DGesGM);Regitz-ZagrosekVLundqvistCBBorghiC, et al.ESC Guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC). Eur Heart J. 2011;32(1):3147–3197.
81.
KnightBPPelosiFMichaudGFStrickbergerSAMoradyF. Physician interpretation of electrocardiographic artifact that mimics ventricular tachycardia. Am J Med. 2001;110(5):335–338.
82.
TeranFDeanAJCentenoC, et al.Evaluation of out-of-hospital cardiac arrest using transesophageal echocardiography in the emergency department. Resuscitation. 2019;137(4):140–147.
83.
FruminHFurmanS. Endless loop tachycardia started by an atrial premature complex in a patient with a dual chamber pacemaker. J Am Coll Cardiol. 1985;5(2):707–710.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
